Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type Clinical Trials in Rochester, Minnesota

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy